Zephyrnet Logo

Tag: fda

Eisai Completes Submission of LEQEMBI (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease to the U.S....

TOKYO and CAMBRIDGE, Mass., Apr 1, 2024 - (JCN Newswire) - Eisai Co., Ltd. and Biogen Inc. announced today that Eisai submitted to the...

Fractyl Secures FDA Approval for Weight Maintenance Study After Discontinuation of GLP-1s | BioSpace

Pictured: Exterior of an FDA building/iStock, Grandbrothers Fractyl Health, which went public in February 2024, got some good and bad news on Monday as it...

Judge Denies Injunction For Tyvaso Drug Competitor – Law360

By Jared Foretek (March 29, 2024, 9:32 PM EDT) -- A D.C. federal judge Friday denied drugmaker United Therapeutics Corp.'s attempt to preemptively...

Judge Denies Injunction For Tyvaso Drug Competitor – Law360 UK

By Jared Foretek (March 29, 2024, 9:32 PM EDT) -- A D.C. federal judge Friday denied drugmaker United Therapeutics Corp.'s attempt to preemptively...

Is The Administration Racing To Reschedule By 4/20

After dragging their feet  for 3 years, the Biden administration seems to be putting some juice to get the DEA to move Is it opening the...

NMPA Usability Engineering Guideline Issued for Medical Devices

NMPA published the “Medical Devices Usability Engineering Guideline” on March 19, 2024. NMPA believes that, in improving the usability and the design of devices...

PassPort Technologies, Inc. Announces Positive Interim Phase I Results of Zolmitriptan Transdermal Microporation System for the Treatment of Acute Migraine | BioSpace

SAN DIEGO, March 29, 2024 /PRNewswire/ -- PassPort Technologies, Inc. (PPTI), based in San Diego, a clinical-stage drug and medical device development company, today...

Latest Intelligence

spot_img
spot_img

Chat with us

Hi there! How can I help you?